SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Tue May 20th - #SSII #TCRX #QMCO #OPTN #MTVA #CING #ASPI #CVU #RZB - More: crystalequityresearch.com/SmCpStr/ - #smallcap

OPTN Modernization and Emergency Policy Issues This symposium was recorded at the 2025 Cutting Edge of Transplantation meeting.

Missed CEoT 2025? Check out this session on #OPTN Modernization and Emergency Policy Issues.

bit.ly/440eQOR

M&A Class Action Firm Investigates Mergers: OPTN, SLRN, AKYA, SHYF Monteverde & Associates PC is investigating mergers involving OPTN, SLRN, AKYA, and SHYF. Shareholders can seek recovery and insights.

M&A Class Action Firm Investigates Mergers: OPTN, SLRN, AKYA, SHYF #United_States #New_York #Mergers #Monteverde #OPTN

Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights Optinose (NASDAQ:OPTN) reported strong financial results for Q4 and full year 2024. XHANCE net revenue reached $22.4 million in Q4 2024 (up 13% YoY) and $78.2 million for full year 2024 (up 10% YoY).The company experienced significant prescription growth, with Total Prescriptions (TRx) increasing 23% from Q3 to Q4 2024 (63,900 to 78,500) and New Prescriptions (NRx) rising 12% (25,600 to 28,700).Notable achievements include the company's first-ever quarterly operating income of $0.4 million in Q4 2024. Operating expenses (SG&A plus R&D) totaled $87.3 million for 2024, up from $85.1 million in 2023. The company reported a net loss of $0.4 million ($0.04 per share) for Q4 and $21.5 million ($2.12 per share) for full year 2024. Cash position remained strong at $84.5 million as of December 31, 2024.

#OPTN Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights

www.stocktitan.net/news/OPTN/optinose-repor...

News; ( NASDAQ: #OPTN ) Expected US Company Earnings on Thursday, March 20th, 2025

Paratek Acquisition Prompts Optinose to Skip Q4 Earnings Call - What's Next for Investors Amid pending acquisition by Paratek, Optinose confirms Q4 and FY2024 financial results will be released as planned, despite earnings call cancellation. Key updates expected.

#OPTN Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call

www.stocktitan.net/news/OPTN/optinose-cance...

Optinose to Reveal Full Year Performance: Key Financial Results Coming March 20 Optinose leadership team to discuss Q4 and 2024 results in March 20 conference call. Pre-market announcement followed by 8:00 AM ET investor presentation and corporate updates.

#OPTN Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/OPTN/optinose-annou...

Learn about Transplantation - OPTN The OPTN is operated under contract with the U.S. Dept. of Health and Human Services by the United Network for Organ Sharing (UNOS). This Web site provides data and educational information about organ...

Organ Procurement,
the procurement process explained
#organprocurement #UNOS #OPTN #HRSA #hearttransplant
#organtransplant #liveonny
optn.transplant.hrsa.gov/patients/abo...

🚨 Big changes coming to the Organ Procurement and Transplantation Network (OPTN) in 2025! 🚨

Learn how modernization efforts aim to improve efficiency and transparency in organ donation & transplantation. Watch here: youtu.be/-wIFFfgLTH8 📺

#OPTN #OrganDonation #Transplantation

Optinose Reports Strong Q4: XHANCE Revenue Hits $22.4M with 20% Prescription Growth Optinose announces preliminary Q4 XHANCE net revenue of $22.4M, achieving 20% sequential prescription growth. Full financial results expected in March 2024.

#OPTN Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million

www.stocktitan.net/news/OPTN/optinose-annou...

Optinose Announces 1-for-15 Reverse Stock Split Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it will effect a 1-for-15 reverse stock split at 5:00 p.m. Eastern Standard Time, on

#OPTN Optinose Announces 1-for-15 Reverse Stock Split

www.stocktitan.net/news/OPTN/optinose-annou...

Pls support the #HOLD Act and #OPTN fee provisions to help kidney patients. I just contacted my senators and representative to urge them to put these noncontroversial, no-cost measures back in the year-end package. Pls contact Congress. They're voting today! kidney.quorum.us/campaign/104...

👀 #CAV patients listed for #HeartTransplant face higher mortality than others at the same status.

Status 4 = Status 3
Status 3 = Status 2
Guess we need to get our #OPTN priorities straight 🥁

www.sciencedirect.com/science/arti...

#CardioSky #MedSky #TransplantEquity #HealthEquity

Federal Register :: Request Access Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs.

excited to see the Final Rule modifying the implementation of the HOPE Act. Making transplant betweeen people living with HIV more like standard of care and opening the opportunity to non-kidney and non-liver transplants! Next step - implementation by #OPTN.

A massive overhaul of the U.S. organ allocation system is upon us. Apparently, #UNOS #OPTN and much of the current OPO infrastructure may be on sale in a competitive bidding process. A step forward or back?

#livertwitter #GITwitter ...

Honored to represent @SRTRNews at @UNOSNews #LivingDonorCmte 🦋 | March 3, 2023 | Chicago, IL🌇
• 🙏🏾Thanks to Cmte & #OPTN Staff for robust discussion🙌🏾
• Privilege to engage in unique '#PatientProfessional' collaboration🤝🏽that defines the #mission of the #LivingDonor Cmte 👐🏾

Honored to represent @SRTRNews at @UNOSNews #LivingDonorCmte 🦋 | March 3, 2023 | Chicago, IL🌇
• 🙏🏾Thanks to Cmte & #OPTN Staff for robust discussion🙌🏾
• Privilege to engage in unique '#PatientProfessional' collaboration🤝🏽that defines the #mission of the #LivingDonor Cmte 👐🏾

Honored to help represent @SRTRNews at #OPTN #BoardOfDirectors Mtg | December 5, 2022 | St. Louis, MO🏛️
• Our work includes supporting the #transplant community w/ analyses📊, to better patient results & experience |🙌🏾#Collaboration | #PatientCentered | #DataDriven | @UNOSNews👐🏾

Honored to help represent @SRTRNews at #OPTN #BoardOfDirectors Mtg | December 5, 2022 | St. Louis, MO🏛️
• Our work includes supporting the #transplant community w/ analyses📊, to better patient results & experience |🙌🏾#Collaboration | #PatientCentered | #DataDriven | @UNOSNews👐🏾

@AASLDtweets my take on updated #HCC allocation: empirical, poorly thought out and like to greatly disadvantage #HCC patients #unos #optn #LiverMtg19